7 insiders reported 89 Form 4 transactions for IOVANCE BIOTHERAPEUTICS, INC. (IOVA) over the past 18 months (most recent 2026-08-12). Recent activity: Kirby Daniel Gordon (Chief Commercial Officer) Sell 2,436 shares, Kirby Daniel Gordon (Chief Commercial Officer) Buy 10,001 shares, Roche Corleen M. (Chief Financial Officer) Buy 49,995 shares, Roche Corleen M. (Chief Financial Officer) Sell 21,238 shares, BILINSKY IGOR (Chief Operating Officer) Buy 7,813 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Kirby Daniel Gordon | Chief Commercial Officer | Sell | 2,436 | $15,590 |
| 2026-08-12 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | 10,001 | $0 |
| 2026-08-10 | Roche Corleen M. | Chief Financial Officer | Buy | 49,995 | $0 |
| 2026-08-10 | Roche Corleen M. | Chief Financial Officer | Sell | 21,238 | $131,888 |
| 2026-06-09 | BILINSKY IGOR | Chief Operating Officer | Buy | 7,813 | $0 |
| 2026-06-09 | Vogt Frederick G | Interim CEO & General Counsel | Buy | 15,625 | $0 |
| 2026-06-09 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Buy | 7,813 | $0 |
| 2026-06-09 | Puri Raj K. | Chief Regulatory Officer | Buy | 9,766 | $0 |
| 2026-06-09 | BILINSKY IGOR | Chief Operating Officer | Sell | 3,976 | $16,818 |
| 2026-06-09 | Vogt Frederick G | Interim CEO & General Counsel | Sell | 6,638 | $28,079 |
| 2026-06-09 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Sell | 3,976 | $16,818 |
| 2026-06-09 | Puri Raj K. | Chief Regulatory Officer | Sell | 3,843 | $16,256 |
| 2026-06-03 | BILINSKY IGOR | Chief Operating Officer | Buy | 8,790 | $0 |
| 2026-06-03 | Vogt Frederick G | Interim CEO & General Counsel | Buy | 41,668 | $0 |
| 2026-06-03 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Buy | 8,790 | $0 |
| 2026-06-03 | Puri Raj K. | Chief Regulatory Officer | Buy | 5,469 | $0 |
| 2026-06-03 | BILINSKY IGOR | Chief Operating Officer | Sell | 4,473 | $17,713 |
| 2026-06-03 | Vogt Frederick G | Interim CEO & General Counsel | Sell | 17,701 | $70,096 |
| 2026-06-03 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Sell | 4,473 | $17,713 |
| 2026-06-03 | Puri Raj K. | Chief Regulatory Officer | Sell | 2,508 | $9,932 |
| 2026-05-13 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | 10,000 | $0 |
| 2026-05-13 | Kirby Daniel Gordon | Chief Commercial Officer | Sell | 2,435 | $9,010 |
| 2026-03-06 | Vogt Frederick G | Interim CEO & General Counsel | Buy | 62,493 | $0 |
| 2026-03-06 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Buy | 31,246 | $0 |
| 2026-03-06 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Sell | 16,520 | $75,662 |
Source: SEC Form 4 filings · as of 2026-08-12